Authors:
ROGHMANN MC
SIDDIQI A
PLAISANCE K
STANDIFORD H
Citation: Mc. Roghmann et al., THE RISK OF MRSA BACTEREMIA IN INPATIENTS WITH CHRONIC ULCERS, Infection control and hospital epidemiology, 19(9), 1998, pp. 14-14
Authors:
PLAISANCE K
ZHOU H
LEE P
HASSELL A
WU J
TRAVERS S
CHAN K
PESCOKOPLOWITZ L
Citation: K. Plaisance et al., PHARMACOKINETICS OF IV ITRACONAZOLE (ITR) IN SUBJECTS WITH VARYING DEGREES OF RENAL-FUNCTION, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 40-40
Authors:
PLAISANCE K
BURSTEIN A
ZHOU H
LEE P
HASSELL A
WU J
TRAVERS S
YOUNG D
PESCOKOPLOWITZ L
Citation: K. Plaisance et al., PHARMACOKINETICS (PK) OF HYDROXYPROPYL-BETA-CYCLODEXTRIN (HPC) IN SUBJECTS WITH VARYING DEGREES OF RENAL-FUNCTION, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 122-122
Citation: S. Bigora et al., INABILITY OF VANCOMYCIN POPULATION-MODELS TO ACCURATELY PREDICT CONCENTRATIONS (C) IN NEONATES, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 78-78
Authors:
PLAISANCE K
PISCITELLI DA
YOUNG D
BIGORA S
PERDUE B
KEAY S
GAINES K
JUNG D
BUHLES W
Citation: K. Plaisance et al., EXPOSURE PARAMETERS AND OUTCOME OF CMV RETINITIS FOR ORAL GANCICLOVIR, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 177-177
Authors:
PISCITELLI DA
PLAISANCE K
YOUNG D
BIGORA S
PERDUE B
GAINES K
JUNG D
BUHLES W
Citation: Da. Piscitelli et al., NONLINEAR MIXED EFFECTS MODELING (NONMEM) OF THE POPULATION PHARMACOKINETICS (PPK) OF ORAL GANCICLOVIR (GA), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 214-214
Authors:
DRUSANO GL
FORREST A
YUEN G
PLAISANCE K
LESLIE J
Citation: Gl. Drusano et al., OPTIMAL SAMPLING THEORY - EFFECT OF ERROR IN A NOMINAL PARAMETER VALUE ON BIAS AND PRECISION OF PARAMETER-ESTIMATION, Journal of clinical pharmacology, 34(10), 1994, pp. 967-974
Authors:
YOUNG D
LAL RA
DEVANE J
PLAISANCE K
BENOWITZ NL
Citation: D. Young et al., MODELING THE CHANGE IN NICOTINE (NIC) PHARMACOKINETICS (PK) DURING NIC INFUSION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 145-145